PCSK9 and Sepsis: In summary, our research results propose a working model by which PCSK9 amplifies sepsis-induced lung injury through a dual mechanism: (1) Directly activating platelets and enhancing coagulant and adhesion properties; (2) Promote the formation of NETs, and facilitate microvascular occlusion and endothelial injury.